CA2826871A1 - 3-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof - Google Patents

3-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof Download PDF

Info

Publication number
CA2826871A1
CA2826871A1 CA2826871A CA2826871A CA2826871A1 CA 2826871 A1 CA2826871 A1 CA 2826871A1 CA 2826871 A CA2826871 A CA 2826871A CA 2826871 A CA2826871 A CA 2826871A CA 2826871 A1 CA2826871 A1 CA 2826871A1
Authority
CA
Canada
Prior art keywords
group
formula
salt
compound
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2826871A
Other languages
English (en)
French (fr)
Inventor
Kazuhiro Kudou
Noriyoshi Yamamoto
Masakazu Ban
Atsushi Ohno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ayumi Pharmaceutical Corp
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of CA2826871A1 publication Critical patent/CA2826871A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
CA2826871A 2011-02-09 2012-02-08 3-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof Abandoned CA2826871A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011026188 2011-02-09
JP2011-026188 2011-02-09
PCT/JP2012/052824 WO2012108455A1 (ja) 2011-02-09 2012-02-08 ３－ヒドロキシ－６Ｈ－ベンゾ［ｃ］クロメン－６－オン誘導体およびその製造方法

Publications (1)

Publication Number Publication Date
CA2826871A1 true CA2826871A1 (en) 2012-08-16

Family

ID=46638668

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2826871A Abandoned CA2826871A1 (en) 2011-02-09 2012-02-08 3-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof

Country Status (8)

Country Link
US (2) US8802869B2 (enExample)
EP (1) EP2674422A4 (enExample)
JP (1) JP5921235B2 (enExample)
KR (1) KR20140002735A (enExample)
CN (1) CN103370310A (enExample)
CA (1) CA2826871A1 (enExample)
TW (1) TW201309663A (enExample)
WO (1) WO2012108455A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
US9394269B2 (en) 2013-12-23 2016-07-19 Amazentis Sa Process-scale synthesis of urolithins
WO2015154047A1 (en) * 2014-04-03 2015-10-08 Restorgenex Corporation Novel methods
CN105884739B (zh) * 2016-04-14 2018-04-27 广西大学 一种苯并香豆素多环化合物的合成方法
EP3639854A4 (en) 2017-06-16 2021-03-03 The Doshisha MTOR INHIBITIVE MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF OPHTHALMIC SYMPTOMS, DISORDERS, OR DISEASES AND USE THEREOF
US20200121652A1 (en) 2017-06-16 2020-04-23 The Doshisha Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent
CN112074510A (zh) * 2018-02-27 2020-12-11 阿马曾提斯公司 尿石素a的工业规模合成
CN111039913A (zh) * 2018-10-15 2020-04-21 韦忠友 一种具有抗肿瘤作用的化合物的制备方法
AU2022212883A1 (en) 2021-01-27 2023-08-17 Vandria Sa Urolithin derivatives and methods of use thereof
WO2024091983A1 (en) 2022-10-25 2024-05-02 Artus Therapeutics, Inc. Therapeutic agents for enhancing epithelial and/or endothelial barrier function
CN119661547A (zh) * 2023-09-20 2025-03-21 科辉智药(深圳)新药研究中心有限公司 作为sarm1酶活性抑制剂的三环吡啶类化合物及其应用
CN117756766A (zh) * 2023-12-20 2024-03-26 常州大学 3-羟基-8-氟-6H-苯并[c]色烯-6-酮类衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073612A2 (en) * 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
CA2621292C (en) 2005-09-14 2014-05-27 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
PL2085387T3 (pl) 2006-11-14 2013-09-30 Ayumi Pharmaceutical Corp Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową
GEP20146061B (en) * 2008-05-12 2014-03-25 Santen Pharmaceutical Co Ltd Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl- 1,2-dihydroquinoline derivative having substituted oxy group

Also Published As

Publication number Publication date
JP5921235B2 (ja) 2016-05-24
CN103370310A (zh) 2013-10-23
US8802869B2 (en) 2014-08-12
EP2674422A1 (en) 2013-12-18
JP2012180345A (ja) 2012-09-20
WO2012108455A1 (ja) 2012-08-16
TW201309663A (zh) 2013-03-01
US20140296540A1 (en) 2014-10-02
US20130310576A1 (en) 2013-11-21
EP2674422A4 (en) 2015-01-21
KR20140002735A (ko) 2014-01-08
US9029572B2 (en) 2015-05-12

Similar Documents

Publication Publication Date Title
US8802869B2 (en) 3-hydroxy-6H-benzo [c] chromene-6-one derivative and manufacturing method thereof
KR101595747B1 (ko) 나파모스탯 메실레이트의 제조방법
CN110498770B (zh) 一种制备恶拉戈利中间体的方法
CN114805314B (zh) 一种恩赛特韦的合成方法
JPWO2015118793A1 (ja) （ｒ）−１，１，３−トリメチル−４−アミノインダンの製造方法
CN114685468A (zh) 用于治疗子宫肌瘤的药物的中间体化合物及其制备方法
JP3845059B2 (ja) シロスタゾールの製造方法
CN108026054A (zh) 取代的苯并三唑酚
CN111100110A (zh) 7-哌嗪基苯并噻吩或其盐的制备方法
WO2007135036A1 (en) METHOD OF PREPARING CHIRAL CYCLIC ß-AMINOCARBOXAMIDES
CN109053505A (zh) 一种非罗考昔重要中间体的合成方法
TWI383974B (zh) 用於製備（３ｓ，４ｓ）－４－（（ｒ）－２－（苯甲氧基）十三基）－３－己基－２－氧雜環丁酮之方法以及用於該方法之新穎中間產物
CN105712919A (zh) 酰胺缩合剂在维格列汀合成方法中的应用
ES2307416B1 (es) Procedimiento para obtener montelukast.
IL177039A (en) Process for making rabamifid
CA2999417A1 (en) The process of preparing indoline compounds and a novel indoline salt
CN103030533B (zh) 一种合成双(4-羟基-1-萘基)苯甲醇的工艺方法
CN114933562B (zh) 基于(2-羟基苄基)二取代氧化膦催化的氯喹的高效制备方法
CN110724133A (zh) 一种匹伐他汀钙中间体的制备方法
CN116410178B (zh) 一种奥美拉唑硫醚的制备方法
CN111100111A (zh) 一种制备苯并噻吩衍生物的方法
CN103709089B (zh) 一种制备3-(4’-氯丁基)-5-氰基吲哚的方法
CN111187197B (zh) 一种Tezacaftor中间体的合成方法
WO1995022531A1 (en) Process for producing 6-substituted 2(1h)-quinoxalinone
CN117886709A (zh) 一种罗贝考昔的合成方法

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180208